Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.36% | -16.30% | -38.51% | -53.21% | -56.57% |
| Total Depreciation and Amortization | 28.52% | 38.17% | 61.18% | 100.56% | 142.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,594.21% | 589.65% | 372.29% | 1,196.30% | -144.44% |
| Change in Net Operating Assets | -125.77% | -181.47% | -169.99% | -147.57% | -138.03% |
| Cash from Operations | -19.32% | -3,252.43% | -1,861.59% | -594.83% | -407.53% |
| Capital Expenditure | 68.27% | 61.01% | 55.77% | 38.23% | 29.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -253.10% | -22.20% | 125.76% | 121.08% | 151.33% |
| Cash from Investing | -292.76% | -4.27% | 119.71% | 114.36% | 137.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -100.00% | -98.21% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 31.55% | -8,217.95% | -- | -- |
| Cash from Financing | 8,201.68% | -15.32% | -18.37% | -51.52% | -99.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.49% | -288.28% | 123.48% | -80.64% | -130.36% |